Trustmark National Bank Trust Department’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,631
Closed -$202K 270
2016
Q2
$202K Sell
1,631
-622
-28% -$75.1K 0.03% 275
2016
Q1
$254K Buy
2,253
+148
+7% +$15.4K 0.03% 258
2015
Q4
$229K Buy
2,105
+43
+2% +$4.92K 0.03% 285
2015
Q3
$206K Buy
+2,062
New +$224K 0.03% 324

Other funds holding CLB

Trustmark National Bank Trust Department's CLB Position: Q3 2016 in Review

Trustmark National Bank Trust Department sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 1,631 shares — an estimated $202K sold.

Trustmark National Bank Trust Department first reported a position in CLB in Q3 2015 and held it in 4 quarters. The position peaked at $254K in Q1 2016. 373 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Trustmark National Bank Trust Department reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 1,631 Core Laboratories shares in Q3 2016, an estimated $202K.
  • Trustmark National Bank Trust Department first reported a position in Core Laboratories in Q3 2015 and held it in 4 quarters.
  • Trustmark National Bank Trust Department's Core Laboratories position peaked at $254K in Q1 2016.
  • 373 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2016, filed 10 Nov 2016.